Search Results 1311-1320 of 18402 for Immunode
Participant is known to be seropositive for human immunodeficiency virus (HIV) or hepatitis B (defined by a positive test for hepatitis B surface antigen ...
History of positive human immunodeficiency virus infection (HIV), congenital and acquired immunodeficiencies (eg, common variable immunodeficiency, ...
Positive human immunodeficiency virus (HIV) serological test at screening, not controlled with antiviral therapy as shown by CD4+ counts ≤200/μL or by a ...
... immunodeficiency virus (positive HIV 1/2 antibodies). Patients with a past or resolved HBV infection (defined as the presence of hepatitis B core antibody ...
Known positive status for human immunodeficiency virus (HIV) and/or active hepatitis B or C; Pregnant or nursing women. Pregnant and nursing patients are ...
Patients known to be human immunodeficiency virus (HIV) positive may be enrolled if baseline CD4 count is > 500 cells/mm³ and they are not taking anti- ...
Human immunodeficiency virus positive, acute liver disease, or unstable chronic liver disease. Any history of colon cancer. History of any other cancers ...
Patients will be recruited regardless of human immunodeficiency virus (HIV) status. Exclusion Criteria: Patients less than 18 years of age. Participating ...
- Human immunodeficiency virus (HIV)-infected patients on effective anti-retro-viral therapy with undetectable viral load within 6 months are eligible for ...
The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.